busulfan has been researched along with Leukocyte-Adhesion Deficiency Syndrome in 3 studies
Leukocyte-Adhesion Deficiency Syndrome: Rare, autosomal recessive disorder caused by deficiency of the beta 2 integrin receptors (RECEPTORS, LEUKOCYTE-ADHESION) comprising the CD11/CD18 family of glycoproteins. The syndrome is characterized by abnormal adhesion-dependent functions, especially defective tissue emigration of neutrophils, leading to recurrent infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peranteau, WH | 1 |
| Heaton, TE | 1 |
| Gu, YC | 2 |
| Volk, SW | 1 |
| Bauer, TR | 2 |
| Alcorn, K | 1 |
| Tuschong, LM | 2 |
| Johnson, MP | 1 |
| Hickstein, DD | 2 |
| Flake, AW | 1 |
| Sokolic, RA | 1 |
| Hai, M | 1 |
| Burkholder, T | 1 |
| Colenda, L | 1 |
| Bacher, J | 1 |
| Starost, MF | 1 |
| Yoshimoto, A | 1 |
| Hashii, Y | 1 |
| Kashiwagi, H | 1 |
| Koizumi, M | 1 |
| Tokimasa, S | 1 |
| Fujisaki, H | 1 |
| Ohta, H | 1 |
| Hanai, N | 1 |
| Ozono, K | 1 |
| Hara, J | 1 |
3 other studies available for busulfan and Leukocyte-Adhesion Deficiency Syndrome
| Article | Year |
|---|---|
Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.
Topics: Animals; Busulfan; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dogs; Female; Fetal T | 2009 |
Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency.
Topics: Animals; Bone Marrow Transplantation; Busulfan; Cyclosporine; Dog Diseases; Dogs; Follow-Up Studies; | 2005 |
Successful allogeneic stem cell transplant for leukocyte adhesion deficiency using an adjusted busulfan-containing regimen.
Topics: Busulfan; Follow-Up Studies; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Immun | 2007 |